A focused educational session on acid suppressive therapy was recently delivered to the Emergency Department (ED) medical team at the National Heart Institute (IJN), highlighting the clinical role of proton pump inhibitors (PPIs)—with particular emphasis on Nexium (esomeprazole).
The talk covered the mechanism of action of PPIs in inhibiting gastric acid secretion, and their critical role in managing stress-related mucosal disease, gastroesophageal reflux (GERD), upper gastrointestinal bleeding, and NSAID-induced gastritis—all relevant scenarios in emergency and cardiology settings.
Discussions also addressed the onset of action, dosing strategies, and appropriate indications of Nexium, reinforcing the importance of targeted therapy to avoid overuse or misuse of PPIs, which can be associated with long-term risks such as hypomagnesemia, C. difficile infection, and osteoporosis.
This session aimed to empower IJN ED doctors with practical knowledge for evidence-based use of PPIs, ensuring optimal patient outcomes in acute care.
Thanks AZ for the opportunity & thanks Dr Farina, Dr Suhailan for attending!